Medical Asset Lead Director, Oncology

🔥 13 hours ago

🇺🇸 United States – Remote

💵 $217.7k - $294.5k / year

⏰ Full Time

🟠 Senior

👨‍⚕️ Medical Director

🦅 H1B Visa Sponsor

This company has sponsored H1B visas in the past.

Apply Now

Find Similar Remote Jobs

Set Up Email Alert For New Jobs

📊 Check your resume score for this job

Improve your chances of getting an interview by checking your resume score before you apply.

Upload Resume

Amgen

WebsiteLinkedInAll Job Openings

10,000+ employees

Founded 1980

🧬 Biotechnology

💊 Pharmaceuticals

🔬 Science

💰 $28.5G Post-IPO Debt on 2022-12

Biotechnology • Pharmaceuticals • Science

Amgen is a global leader in biotechnology, focusing on the development and commercialization of innovative medicines made from living cells. The company aims to treat serious illnesses, often targeting diseases with limited therapeutic options. Amgen emphasizes scientific innovation and is committed to ethical research, patient safety, and environmental sustainability. It actively engages in clinical trials and is known for its contributions to the fields of cancer treatment and obesity management among others.

📋 Description

• Be accountable for the development and execution of the global medical affairs strategy across the Hematology portfolio. • Lead the Global Medical Affairs Hematology Team. • Maximize Amgen’s medical value proposition, advancing evidence generation. • Provide medical and scientific insights to support development of the Target Product Profile and asset strategy. • Capture clinical, scientific, patient, payer, and health system insights across key markets. • Coordinate with regions to develop and lead the external stakeholder management plan, communication strategy, scientific platform, publication plan, and evidence generation plan. • Facilitate scientific engagement with a broad range of external stakeholders, including opinion leaders, professional organizations, advocacy groups, payers, regulators, and other healthcare decision makers. • Provide strategic direction for study design and execution for medical affairs studies.

🎯 Requirements

• Doctorate degree and 4 years of medical affairs or clinical development experience in the relevant therapeutic area OR Master’s degree and 7 years of medical affairs or clinical development experience in the relevant therapeutic area OR Bachelor’s degree and 9 years of medical affairs or clinical development experience in the relevant therapeutic area • MD/DO degree from an accredited medical school, PhD, or PharmD preferred. • 5+ years of clinical research and/or medical affairs experience in a leadership role. • Minimum of 5 years of Medical Affairs experience in the biopharmaceutical industry, including biotechnology, pharmaceutical, or CRO experience. • Demonstrated expertise in malignant hematology, including leukemia, lymphoma, myeloma, or related disorders, with a strong understanding of evolving treatment paradigms and competitive landscapes. • Experience building and executing Integrated Evidence Generation Plans. • Ability to establish effective interactions and engagements with external stakeholders, including opinion leaders, advocacy groups, patients, payers, vendors, professional organizations, and other healthcare decision makers. • Familiarity with global regulatory organizations, guidelines, and practices. • Knowledge of Good Clinical Practices, global regulations, and applicable medical affairs guidelines. • Strong understanding of healthcare systems around the world, including the U.S., Europe, and Asia. • Excellent communication, collaboration, strategic planning, and executive presence.

🏖️ Benefits

• A comprehensive employee benefits package, including a Retirement and Savings Plan with generous company contributions • Group medical, dental and vision coverage • Life and disability insurance • Flexible spending accounts • A discretionary annual bonus program, or for field sales representatives, a sales-based incentive plan • Stock-based long-term incentives • Award-winning time-off plans • Flexible work models where possible.